SymThera ^Companies

SymThera is a biopharmaceutical company that focuses on the rapid development and commercialization of innovative pharmaceutical products for the treatment of Metastatic Cancer. They have developed proprietary in silico drug discovery algorithms that identify consensus amino acid sequences shared by, or unique to disease-associated proteins. This allows them to validate disease-related targets and simultaneously identify drug leads that impact the network. SymThera is the first biotechnology company to apply the power of network theory to drug discovery and has pioneered a novel approach to modulating the immune network. Their goal is to develop effective treatments for Metastatic Cancer using their unique technology platform.